Core Insights - The company Shijiazhuang Pharmaceutical Group (石四药集团) has received approval from the National Medical Products Administration of China for three active pharmaceutical ingredients (APIs): Fenofibrate, Fenofibric Acid, and Sodium Phosphate of Levofloxacin [1] - Among these, Sodium Phosphate of Levofloxacin is the third API approved for use in China by domestic companies [1] Group 1: Product Approvals - Fenofibrate and Fenofibric Acid are primarily used for treating hyperlipidemia and hypercholesterolemia, as well as for lowering triglyceride levels in patients with severe hypertriglyceridemia [1] - Sodium Phosphate of Levofloxacin is mainly used for treating severe amoebic infections of the intestine and liver, infections caused by anaerobic bacteria sensitive to Metronidazole post-surgery, and for preventing infections from anaerobic bacteria during surgical procedures [1]
石四药集团：非诺贝特、非诺贝特酸胆硷、及磷酸左奥硝唑酯二钠已获批登记成为在上市制剂使用的原料药